MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1 to 20 of 166,322 approvalsPage 1 of 8317

Sacubitril Valsartan Sodium Tablets

Approval Number: 国药准字H20254532
Registration: Jun 10, 2025

Ceftizoxime Sodium for Injection

Approval Number: 国药准字H20254471
Registration: Jun 10, 2025

Diprophylline Injection

Approval Number: 国药准字H20254515
Registration: Jun 10, 2025

Levocarnitine Oral Solution

Approval Number: 国药准字H20254529
Registration: Jun 10, 2025

Dopamine Hydrochloride Injection

Approval Number: 国药准字H20254504
Registration: Jun 10, 2025

Sacubitril Valsartan Sodium Tablets

Approval Number: 国药准字H20254531
Registration: Jun 10, 2025

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20254478
Registration: Jun 10, 2025

Procaterol Hydrochloride Inhalation Solution

Approval Number: 国药准字H20254534
Registration: Jun 10, 2025

Nicorandil for Injection

Approval Number: 国药准字H20254521
Registration: Jun 10, 2025

Rivastigmine Transdermal Patch

Approval Number: 国药准字H20254469
Registration: Jun 10, 2025

Dopamine Hydrochloride Injection

Approval Number: 国药准字H20254503
Registration: Jun 10, 2025

Isosorbide Dinitrate Injection

Approval Number: 国药准字H20254468
Registration: Jun 10, 2025

Fusidic Acid Cream

Approval Number: 国药准字H20254526
Registration: Jun 10, 2025

Piracetam Injection

Approval Number: 国药准字H20254518
Registration: Jun 10, 2025

Amikacin Sulfate Injection

Approval Number: 国药准字H20254512
Registration: Jun 10, 2025

Procaterol Hydrochloride Oral Solution

Approval Number: 国药准字H20254528
Registration: Jun 10, 2025

Oxacillin Sodium for Injection

Approval Number: 国药准字H20254495
Registration: Jun 10, 2025

Urapidil Hydrochloride Injection

Approval Number: 国药准字H20254524
Registration: Jun 10, 2025

Cefazolin Sodium for Injection/Sodium Chloride Injection

Approval Number: 国药准字H20254505
Registration: Jun 10, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.